Stemcells (NASDAQ: STEM) reported Q2 EPS of ($0.22), $0.08 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $242 thousand versus the consensus estimate of $260 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.